Antiretroviral drugs during breast-feeding cut HIV transmission

04/26/2012 | PhysiciansBriefing.com

The cumulative risk of HIV-1 mother-to-infant transmission at 48 weeks was significantly lower among breast-feeding HIV-positive mothers who received antiretroviral drugs or whose infants received antiretroviral drugs, CDC researchers wrote in the journal The Lancet. The trial in Malawi also found a greater risk of diarrhea, delayed growth, malaria, tuberculosis and death in infants after weaning by 28 weeks.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN